Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential 6-TG After MTX in Relapsed Hodgkin's Disease
NCT00587873Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Mar 1994
- Primary completion
- Dec 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, tioguanine in Hodgkin lymphoma (HL), sponsored by Memorial Sloan Kettering Cancer Center. Started Mar 1994; status: completed.
02
Drugs
methotrexatetioguanine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00587873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00587873.